Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 16;25(16):8921.
doi: 10.3390/ijms25168921.

A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis

Affiliations
Review

A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis

Ida Manna et al. Int J Mol Sci. .

Abstract

According to various research, the risk of multiple sclerosis (MS) is strongly influenced by genetic variations. Population, familial, and molecular studies provide strong empirical support for a polygenic pattern of inheritance, mainly due to relatively common allelic variants in the general population. The strongest MS susceptibility locus, which was unmistakably identified in tested populations, is the major histocompatibility complex on chromosome 6p21.3. However, the effect of a given predisposing variant remains modest, so there is the possibility that multiple gene-gene and/or gene-environment interactions could significantly increase the contribution of specific variants to the overall genetic risk. Furthermore, as is known, susceptibility genes can be subject to epigenetic modifications, which greatly increase the complexity of MS heritability. Investigating epigenetic and environmental factors can provide new opportunities for the molecular basis of the MS, which shows complicated pathogenesis. Although studies of epigenetic changes in MS only began in the last decade, a growing body of literature suggests that these may be involved in the development of MS. Here, we summarize recent studies regarding epigenetic changes related to MS initiation and progression. Furthermore, we discuss how current studies address important clinical questions and how future studies could be used in clinical practice.

Keywords: biomarkers; environmental factors; epigenetic modifications; multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Risk factors of multiple sclerosis.
Figure 2
Figure 2
Epigenetic mechanisms.

References

    1. Dendrou C.A., Fugger L., Friese M.A. Immunopathology of multiple sclerosis. Nat. Rev. Immuno. 2015;15:545–558. doi: 10.1038/nri3871. - DOI - PubMed
    1. Franklin R.J., Ffrench-Constant C. Remyelination in the CNS: From biology to therapy. Nat. Rev. Neurosci. 2008;9:839–855. doi: 10.1038/nrn2480. - DOI - PubMed
    1. Yamout B.I., Alroughani R. Multiple Sclerosis. Semin. Neurol. 2018;38:212–225. - PubMed
    1. Kuhlmann T., Moccia M., Coetzee T., Cohen J.A., Correale J., Graves J., Marrie R.A., Montalban X., Yong V.W., Thompson A.J., et al. International Advisory Committee on Clinical Trials in Multiple Sclerosis. Multiple sclerosis progression: Time for a new mechanism-driven framework. Lancet Neurol. 2023;22:78–88. doi: 10.1016/S1474-4422(22)00289-7. - DOI - PMC - PubMed
    1. Zettl U.K., Stuve O., Patejd R. Immune-mediated CNS diseases: A review on nosological classification and clinical features. Autoimmun. Rev. 2012;11:167–173. doi: 10.1016/j.autrev.2011.05.008. - DOI - PubMed

LinkOut - more resources